1980
DOI: 10.1001/archinte.1980.00330220069024
|View full text |Cite
|
Sign up to set email alerts
|

Cisplatin-Induced Hypocalcemia and Hypomagnesemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0
1

Year Published

1983
1983
2003
2003

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(12 citation statements)
references
References 7 publications
1
10
0
1
Order By: Relevance
“…These findings suggest that previously reported variances in serum immunoreactive PTHlevels are due to differences in the degree (and duration to some extent) of hypomagnesemiaand hypocalcemia. Magnesium supplementation induced a striking increase in mid-region PTHand intact PTHin the present patient as in the previous reports (1 [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] in which serum values ofPTHwere measured with traditional assays. This increase indicates that the stimulating drive for PTHsecretion in response to severe hypocalcemia was suppressed by magnesium depletion.…”
Section: Discussionsupporting
confidence: 83%
See 3 more Smart Citations
“…These findings suggest that previously reported variances in serum immunoreactive PTHlevels are due to differences in the degree (and duration to some extent) of hypomagnesemiaand hypocalcemia. Magnesium supplementation induced a striking increase in mid-region PTHand intact PTHin the present patient as in the previous reports (1 [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] in which serum values ofPTHwere measured with traditional assays. This increase indicates that the stimulating drive for PTHsecretion in response to severe hypocalcemia was suppressed by magnesium depletion.…”
Section: Discussionsupporting
confidence: 83%
“…Both cisplatin (1)(2)(3)(4) and doxorubicin (3,5,6) have already been shown to cause hypomagnesemia due to magnesiumleaking from the kidney.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This chemotherapeutic agent is associated with nephrotoxicity which appears to be dose-dependent [4]. Hypomagnesemia with renal magnesium wasting [5,6], impaired water metabolism [7], hypocalcemia and hypo kalemia [8][9][10] are among the nephrotoxic effects that have been reported following cisplatin administration.…”
Section: Introductionmentioning
confidence: 99%